Everyone has brought some very illuminating perspectives to this thread re News Release - it is good to have other "lurkers" comment (especially new lurkers) to give us a fresh look at all this.
I invite one and all to call Xoma's IR. I spoke with her (Ellen) yesterday. She helped clear up some questions I had. Xoma is definately not a smoke and mirrors company - BPI/Neuprex clearly has positive elements - it is a question of our country having a heavily regulated securities regime, along with an even more heavily regulated drug scanner. No opinion whether that is good or bad, it just is. Irrespective of the stock's prospects (although I remain as optimistic as a speculator can be) it is very comforting having the IR resource. (you should also ask for an "investor's kit")
Re my tel call, The most important issue I think was my understanding that the DSMB matter is not such an on and off switch, and (though I was not given any indication either way) - it is not that easy to get a "halt! - drug is so good give it to everyone". To be sure, there has been some news headlines of some others (the Kaposi Sarcoma cream comes to mind) I tend to agree with some of the other posts here that a more likely scenario is "continue - drug is good, drug continues to be safe, tinker with this, tweek that - now move on to the end of the trial". However, I want to share with you all a mental process I have been going through based on what I perceive as a virtual "non-movement" (even a small downtick) of the stock in the wake of the latest press release.
I feel that everyone is hanging on hearing magic bullet news, particularly those who just jumped on the bandwagon based on the various newsletter recs, CNBC interviews, etc. When I say magic bullet, I mean, I think people want to hear, from the FDA: "STOP - IN THE NAME OF LOVE - Neuprex will save all lives, give it to all! Praise God, Halleluiah we are free at last!!" With that said (and with my assumption that a continued Phase III is more likely (with fingers crossed tho for a halt :> ), with that said I have to ask myself what will I do with my stock if the Street punishes it based on a "continue Phase III - meningoccemia" announcement. I have to ask myself, do I hold tight, and buy more on the dip (if one occurs, I might be wrong), or do I cut my losses. I have learned so much about BPI in the last couple months, I cannot imagine that it will not be effective for numerous (and profitable) applications. I am kinda freaking b/c I went from being a trader to being a long termer - very shocking for me, frankly - perhaps ** I ** need some BPI for my shock. I have actually LEARNED something about a company's product! Well, I am not telling anyone anything they probably do not already know, but my conclusion is that I personally will continue to monitor, will hold tight, if the stock takes a hit, at this point I feel I will simply pick up more on a "blue light special".
My mood, as with my investment style, is subject to change without notice.
Turbo |
